Anadis Partners with Garden State Nutritionals (GSN) for US Market Entry of its Milk-Derived (Colostrum) Bioactive Products
GSN is one of the largest custom contract manufacturers of nutritional supplements in the United States, and is a leading producer of more than $1 billion in finished retail products per year.
17/03/08 Anadis, an Australian Biopharmaceutical company announced its collaboration with Garden State Nutritionals, a New Jersey based division (GSN) of VitaQuest International in the field of dietary supplements. Anadis and GSN plans to introduce in the coming months and years a range of products, all based on Anadis’ proprietary and all-natural milk-derived (colostrum) bioactives and immunoglobulins. The collaboration will allow Anadis to further expedite its penetration into the U.S. Vitamins and dietary supplements, a market which exceeds $15Bn in size, and which experiences growth rate in excess of 5% (Market research/Euro Monitor, 2007).
GSN is one of the largest custom contract manufacturers of nutritional supplements in the United States, and is a leading producer of more than $1 billion in finished retail products per year. With advanced 250,000 sq. ft. manufacturing and packaging facility they produce more than 500 million doses per month and reach all geographical areas of the United States as well as supply to all major regional and national nutritional commercial channels.
“Our expert and dedicated management team has an impressive average of more than 25 years of broad industry experience. We are thrilled to have Anadis with its proprietary Colostrum derived bioactives working with us. We see great potential in introducing Anadis to our more than 300 clients,“ said Jon Weisgal, VP of Marketing, VitaQuest.
Dr. Zeil Rosenberg, Anadis’ New York City-based CEO, said: “GSN develops and manufacture cost-effective, market-leading dietary supplements products in every distribution channel, including health and natural food stores, mass merchandisers, network marketing and direct selling, television shopping, drug chain and direct response TV and radio.”
Dr. Oren Fuerst, Anadis’ New York City-based VP Business Development said: “Collaboration with GSN allows Anadis to offer our marketing partners complete turnkey solutions, including product concepts, formulations, laboratory services, package and label design, regulatory compliance and assistance in marketing and merchandising. The combination of GSN’s skills with our decade of R&D in the field of dairy-derived colostrum bioactives will now allow Anadis to rapidly penetrate the U.S. vitamins and dietary supplements market. This is a four way win combination to Anadis, GSN, the dietary supplements brands under which these products will be marketed, and above all consumers, who will be offered a broad range of new products based on our proprietary, all-natural colostrum platform."
